Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13D for ESSA Pharma Inc. Common Shares (EPIX).
- Disclosed ownership: 20%.
- Date of event: 09 Apr 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 20% ownership in ESSA Pharma Inc. Common Shares (EPIX) on 09 Apr 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND LP | 11% | 4,712,590 | 0 | 4,712,590 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0000918923 |
| BVF I GP LLC | 11% | 4,712,590 | 0 | 4,712,590 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803805 |
| BIOTECHNOLOGY VALUE FUND II LP | 7.9% | 3,491,779 | 0 | 3,491,779 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001102444 |
| BVF II GP LLC | 7.9% | 3,491,779 | 0 | 3,491,779 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803806 |
| Biotechnology Value Trading Fund OS LP | 0.8% | 357,472 | 0 | 357,472 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660683 |
| BVF Partners OS Ltd. | 0.8% | 357,472 | 0 | 357,472 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660684 |
| BVF GP HOLDINGS LLC | 18% | 8,204,369 | 0 | 8,204,369 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803809 |
| BVF PARTNERS L P/IL | 20% | 8,748,629 | 0 | 8,748,629 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001055947 |
| BVF INC/IL | 20% | 8,748,629 | 0 | 8,748,629 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001056807 |
| LAMPERT MARK N | 20% | 8,748,629 | 0 | 8,748,629 | /s/ Mark N. Lampert | Mark N. Lampert | 0001233840 |